Vir Biotechnology, Inc.
COMBINATION HBV THERAPY

Last updated:

Abstract:

The present disclosure provides methods for treating HBV infection using combination therapies, and related kits and compositions for use. The components of the combination therapies include an inhibitor of HBV gene expression or an agent that reduces HBV antigenic load, and an anti-HBV antibody.

Status:
Application
Type:

Utility

Filling date:

19 Dec 2019

Issue date:

24 Feb 2022